Quintiles Introduces Precision Enrollment Offering

Article

Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials.

Quintiles announces its Precision Enrollment offering to accelerate site start-up and patient recruitment in oncology clinical trials. This new model adjusts the traditional site start-up pathway so that it is only opened after a patient is identified.

Read the full release here

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.